SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) July 2, 2002
-------------------
SENESCO TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 001-35354 84-1368850
--------------------------------------------------------------------------------
(STATE OR OTHER JURISDICTION (COMMISSION FILE NUMBER) (IRS EMPLOYER
OF INCORPORATION) IDENTIFICATION NO.)
303 George Street, Suite 420, New Brunswick, New Jersey 08901
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (732) 296-8400
-----------------------------
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
Senesco Technologies, Inc. (the "Company") posted the Company's annual
Letter to Stockholders and a Research and Development update on its Company web
site at www.senesco.com. The Letter to Stockholders reviews corporate events
that occurred during the past fiscal year and outlines key goals and objectives
for the upcoming fiscal year. Specifically, the letter addresses securing
additional long-term equity financing, the Company's new listing on the American
Stock Exchange, its license agreements with Harris Moran Seed Company and
ArborGen, LLC, and its joint venture with Rahan Meristem. The Research and
Development update discusses the expansion of the Company's ongoing research and
development programs, including the potential applicability of the Company's
gene technology in targeting major diseases in humans and animals.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit No. Description of Exhibits
----------- -----------------------
99.1 Press Release dated July 2, 2002, announcing the
posting of the Company's annual Letter to
Stockholders and a Research and Development update
on its Company web site.
99.2 Annual Letter to Stockholders dated July 1, 2002.
99.3 Research and Development update dated July 1, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SENESCO TECHNOLOGIES, INC.
By: /s/ Bruce C. Galton
---------------------------------------
Bruce C. Galton
President and Chief Executive Officer
July 3, 2002